Report Detail

Request for Sample of this report

Pharma & Healthcare Global Vaccine (Include COVID-19) Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4742328
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 139 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Vaccine (Include COVID-19) market size was valued at US$ 63730 million in 2025 and is forecast to a readjusted size of US$ 81210 million by 2032 with a CAGR of 3.6% during review period.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Vaccine (Include COVID-19) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccine (Include COVID-19) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Vaccine (Include COVID-19) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Vaccine (Include COVID-19) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Vaccine (Include COVID-19) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine (Include COVID-19)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine (Include COVID-19) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, KM Biologics, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Vaccine (Include COVID-19) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Market segment by Application
Public
Private
Market segment by players, this report covers
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Vaccine (Include COVID-19) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Vaccine (Include COVID-19), with revenue, gross margin, and global market share of Vaccine (Include COVID-19) from 2021 to 2026.
Chapter 3, the Vaccine (Include COVID-19) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Vaccine (Include COVID-19) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine (Include COVID-19).
Chapter 13, to describe Vaccine (Include COVID-19) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Vaccine (Include COVID-19) by Type
    • 1.3.1 Overview: Global Vaccine (Include COVID-19) Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Vaccine (Include COVID-19) Consumption Value Market Share by Type in 2025
    • 1.3.3 Inactivated Vaccine
    • 1.3.4 Attenuated Vaccine
    • 1.3.5 mRNA
    • 1.3.6 Other
  • 1.4 Global Vaccine (Include COVID-19) Market by Application
    • 1.4.1 Overview: Global Vaccine (Include COVID-19) Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Public
    • 1.4.3 Private
  • 1.5 Global Vaccine (Include COVID-19) Market Size & Forecast
  • 1.6 Global Vaccine (Include COVID-19) Market Size and Forecast by Region
    • 1.6.1 Global Vaccine (Include COVID-19) Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Vaccine (Include COVID-19) Market Size by Region, (2021-2032)
    • 1.6.3 North America Vaccine (Include COVID-19) Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Vaccine (Include COVID-19) Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Vaccine (Include COVID-19) Market Size and Prospect (2021-2032)
    • 1.6.6 South America Vaccine (Include COVID-19) Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Vaccine (Include COVID-19) Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Vaccine (Include COVID-19) Product and Solutions
    • 2.1.4 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Recent Developments and Future Plans
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Vaccine (Include COVID-19) Product and Solutions
    • 2.2.4 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CSL Recent Developments and Future Plans
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Vaccine (Include COVID-19) Product and Solutions
    • 2.3.4 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GSK Recent Developments and Future Plans
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Vaccine (Include COVID-19) Product and Solutions
    • 2.4.4 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Viatris Recent Developments and Future Plans
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Vaccine (Include COVID-19) Product and Solutions
    • 2.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AstraZeneca Recent Developments and Future Plans
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Vaccine (Include COVID-19) Product and Solutions
    • 2.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hualan Bio Recent Developments and Future Plans
  • 2.7 Changchun Institute of Biological
    • 2.7.1 Changchun Institute of Biological Details
    • 2.7.2 Changchun Institute of Biological Major Business
    • 2.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product and Solutions
    • 2.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Changchun Institute of Biological Recent Developments and Future Plans
  • 2.8 Sinovac
    • 2.8.1 Sinovac Details
    • 2.8.2 Sinovac Major Business
    • 2.8.3 Sinovac Vaccine (Include COVID-19) Product and Solutions
    • 2.8.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sinovac Recent Developments and Future Plans
  • 2.9 KM Biologics
    • 2.9.1 KM Biologics Details
    • 2.9.2 KM Biologics Major Business
    • 2.9.3 KM Biologics Vaccine (Include COVID-19) Product and Solutions
    • 2.9.4 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 KM Biologics Recent Developments and Future Plans
  • 2.10 Pfizer
    • 2.10.1 Pfizer Details
    • 2.10.2 Pfizer Major Business
    • 2.10.3 Pfizer Vaccine (Include COVID-19) Product and Solutions
    • 2.10.4 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Pfizer Recent Developments and Future Plans
  • 2.11 Merck
    • 2.11.1 Merck Details
    • 2.11.2 Merck Major Business
    • 2.11.3 Merck Vaccine (Include COVID-19) Product and Solutions
    • 2.11.4 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Merck Recent Developments and Future Plans
  • 2.12 Sinovac
    • 2.12.1 Sinovac Details
    • 2.12.2 Sinovac Major Business
    • 2.12.3 Sinovac Vaccine (Include COVID-19) Product and Solutions
    • 2.12.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sinovac Recent Developments and Future Plans
  • 2.13 Zhejiang Pukang
    • 2.13.1 Zhejiang Pukang Details
    • 2.13.2 Zhejiang Pukang Major Business
    • 2.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product and Solutions
    • 2.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Zhejiang Pukang Recent Developments and Future Plans
  • 2.14 Walvax Biotechnology
    • 2.14.1 Walvax Biotechnology Details
    • 2.14.2 Walvax Biotechnology Major Business
    • 2.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product and Solutions
    • 2.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Walvax Biotechnology Recent Developments and Future Plans
  • 2.15 Bharat Biotech
    • 2.15.1 Bharat Biotech Details
    • 2.15.2 Bharat Biotech Major Business
    • 2.15.3 Bharat Biotech Vaccine (Include COVID-19) Product and Solutions
    • 2.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Bharat Biotech Recent Developments and Future Plans
  • 2.16 Serum Institute
    • 2.16.1 Serum Institute Details
    • 2.16.2 Serum Institute Major Business
    • 2.16.3 Serum Institute Vaccine (Include COVID-19) Product and Solutions
    • 2.16.4 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Serum Institute Recent Developments and Future Plans
  • 2.17 Panacea Biotec Ltd
    • 2.17.1 Panacea Biotec Ltd Details
    • 2.17.2 Panacea Biotec Ltd Major Business
    • 2.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Solutions
    • 2.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Panacea Biotec Ltd Recent Developments and Future Plans
  • 2.18 Bio-Med
    • 2.18.1 Bio-Med Details
    • 2.18.2 Bio-Med Major Business
    • 2.18.3 Bio-Med Vaccine (Include COVID-19) Product and Solutions
    • 2.18.4 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Bio-Med Recent Developments and Future Plans
  • 2.19 Halfkin Bio-Pharmaceuticals
    • 2.19.1 Halfkin Bio-Pharmaceuticals Details
    • 2.19.2 Halfkin Bio-Pharmaceuticals Major Business
    • 2.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Solutions
    • 2.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Halfkin Bio-Pharmaceuticals Recent Developments and Future Plans
  • 2.20 LG Life Sciences
    • 2.20.1 LG Life Sciences Details
    • 2.20.2 LG Life Sciences Major Business
    • 2.20.3 LG Life Sciences Vaccine (Include COVID-19) Product and Solutions
    • 2.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 LG Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Vaccine (Include COVID-19) Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Vaccine (Include COVID-19) by Company Revenue
    • 3.2.2 Top 3 Vaccine (Include COVID-19) Players Market Share in 2025
    • 3.2.3 Top 6 Vaccine (Include COVID-19) Players Market Share in 2025
  • 3.3 Vaccine (Include COVID-19) Market: Overall Company Footprint Analysis
    • 3.3.1 Vaccine (Include COVID-19) Market: Region Footprint
    • 3.3.2 Vaccine (Include COVID-19) Market: Company Product Type Footprint
    • 3.3.3 Vaccine (Include COVID-19) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Vaccine (Include COVID-19) Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Vaccine (Include COVID-19) Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Vaccine (Include COVID-19) Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Vaccine (Include COVID-19) Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Vaccine (Include COVID-19) Consumption Value by Type (2021-2032)
  • 6.2 North America Vaccine (Include COVID-19) Market Size by Application (2021-2032)
  • 6.3 North America Vaccine (Include COVID-19) Market Size by Country
    • 6.3.1 North America Vaccine (Include COVID-19) Consumption Value by Country (2021-2032)
    • 6.3.2 United States Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Vaccine (Include COVID-19) Consumption Value by Type (2021-2032)
  • 7.2 Europe Vaccine (Include COVID-19) Consumption Value by Application (2021-2032)
  • 7.3 Europe Vaccine (Include COVID-19) Market Size by Country
    • 7.3.1 Europe Vaccine (Include COVID-19) Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 7.3.3 France Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Vaccine (Include COVID-19) Market Size by Region
    • 8.3.1 Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Region (2021-2032)
    • 8.3.2 China Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 8.3.5 India Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Vaccine (Include COVID-19) Consumption Value by Type (2021-2032)
  • 9.2 South America Vaccine (Include COVID-19) Consumption Value by Application (2021-2032)
  • 9.3 South America Vaccine (Include COVID-19) Market Size by Country
    • 9.3.1 South America Vaccine (Include COVID-19) Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Country
    • 10.3.1 Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Vaccine (Include COVID-19) Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Vaccine (Include COVID-19) Market Drivers
  • 11.2 Vaccine (Include COVID-19) Market Restraints
  • 11.3 Vaccine (Include COVID-19) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Vaccine (Include COVID-19) Industry Chain
  • 12.2 Vaccine (Include COVID-19) Upstream Analysis
  • 12.3 Vaccine (Include COVID-19) Midstream Analysis
  • 12.4 Vaccine (Include COVID-19) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Vaccine (Include COVID-19). Industry analysis & Market Report on Vaccine (Include COVID-19) is a syndicated market report, published as Global Vaccine (Include COVID-19) Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Vaccine (Include COVID-19) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo